摘要
本文报道40例慢性乙型肝炎患者口服干扰素随机双盲对照治疗一年,结果表明肝功能改善治疗组为50％,对照组为10％;HBSAg滴度下降,eAg转阴同时伴eAb转阳治疗组为30％,对照组为10％。其机理及扩大临床应用有待进一步研究。
This paper presents the study of a double-blind random trial on 40 cases using Oraferon for oneYear. The results showed that ALT and AST level recovered to normal in 50% of cases in thetreated group and 10% in the control group. HBsAg titer dropped and HBeAg reversed to anti-HBe in30% of the cases in the treated groups and 10% in the control group However, further study on themechanism of the action of oraferon and its wider clinical application are expected.
出处
《北京医科大学学报》
CSCD
1993年第2期97-99,共3页
Journal of Peking University(Health Sciences)
关键词
乙型肝炎
干扰素
谷草转氨酶
Chronic Hepatitis B
Oraferon
ALT
AST
HBV mark
